Jose C. Segovia
Jose C. Segovia
Dirección de correo verificada de
TítuloCitado porAño
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
T Kisseleva, H Uchinami, N Feirt, O Quintana-Bustamante, JC Segovia, ...
Journal of hepatology 45 (3), 429-438, 2006
Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells
PJ Real, A Sierra, A de Juan, JC Segovia, JM Lopez-Vega, ...
Oncogene 21 (50), 7611, 2002
Elevated plasma glucagon levels in cirrhosis of the liver
J Marco, J Diego, ML Villanueva, M Díaz-Fierros, I Valverde, JM Segovia
New England Journal of Medicine 289 (21), 1107-1111, 1973
Curcumin protects against acute liver damage in the rat by inhibiting NF-κB, proinflammatory cytokines production and oxidative stress
K Reyes-Gordillo, J Segovia, M Shibayama, P Vergara, MG Moreno, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1770 (6), 989-996, 2007
Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo–expanded human CD34+ cord blood cells
G Güenechea, JC Segovia, B Albella, M Lamana, M Ramırez, C Regidor, ...
Blood 93 (3), 1097-1105, 1999
Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation
N Lindefors, E Brodin, U Tossman, J Segovia, U Ungerstedt
Experimental brain research 74 (3), 527-534, 1989
Resveratrol prevents fibrosis, NF‐κB activation and TGF‐β increases induced by chronic CCl4 treatment in rats
E Chávez, K Reyes‐Gordillo, J Segovia, M Shibayama, V Tsutsumi, ...
Journal of Applied Toxicology: An International Journal 28 (1), 35-43, 2008
Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease
F Perez-Severiano, C Rı́os, J Segovia
Brain research 862 (1-2), 234-237, 2000
Hematopoietic mobilization in mice increases the presence of bone marrow–derived hepatocytes via in vivo cell fusion
O Quintana‐Bustamante, A Alvarez‐Barrientos, AV Kofman, I Fabregat, ...
Hepatology 43 (1), 108-116, 2006
Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway
J Segovia, NJK Tillakaratne, K Whelan, AJ Tobin, K Gale
Brain research 529 (1-2), 345-348, 1990
Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1
S Navarro, NW Meza, O Quintana-Bustamante, JA Casado, A Jacome, ...
Molecular Therapy 14 (4), 525-535, 2006
Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF‐β modulation and oxidative stress
K Reyes‐Gordillo, J Segovia, M Shibayama, V Tsutsumi, P Vergara, ...
Fundamental & clinical pharmacology 22 (4), 417-427, 2008
Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation
F Pérez-Severiano, A Santamaría, J Pedraza-Chaverri, ...
Neurochemical research 29 (4), 729-733, 2004
Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington’s disease mutation
F Perez-Severiano, B Escalante, P Vergara, C Rı́os, J Segovia
Brain research 951 (1), 36-42, 2002
Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar
A Ruiz-Villalba, AM Simón, C Pogontke, MI Castillo, G Abizanda, ...
Journal of the American College of Cardiology 65 (19), 2057-2066, 2015
Extracellular levels of amino acids in striatum and globus pallidus of 6‐hydroxydopamine‐lesioned rats measured with microdialysis
U Tossman, J Segovia, U Ungerstedt
Acta physiologica scandinavica 127 (4), 547-551, 1986
Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters
AM Estrada-Sánchez, T Montiel, J Segovia, L Massieu
Neurobiology of disease 34 (1), 78-86, 2009
Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats
JA Gonzalez-Barrios, M Lindahl, MJ Bannon, V Anaya-Martínez, G Flores, ...
Molecular therapy 14 (6), 857-865, 2006
Cyclic AMP Decreases the Expression of a Neuronal Marker (GAD67) and Increases the Expression of an Astroglial Marker (GFAP) in C6 Cells
J Segovia, GM Lawless, NJK Tillakaratne, M Brenner, AJ Tobin
Journal of neurochemistry 63 (4), 1218-1225, 1994
A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts
The FASEB Journal 15 (9), 1529-1538, 2001
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20